Home Aimorphous Health

Aimorphous Health

Aimorphous Health

Aimorphous Health
Category
Business Description
Aimorphous Health (AH) AG, a Swiss med tech startup, is developing a cutting-edge AI-powered blood diagnostic device, which will provide the state-of-the-art diagnostics and prediction of thrombosis and bleeding risks. The technology is developed based on a patented novel biomarker developed by AH which reveals day-to-day changes in the risks.
Long Business Description

Our mission is the development of an advanced AI-powered medical device with the primary objective of mitigating fatalities associated with blood clots occurring in conditions such as strokes and heart attacks. By harnessing the capabilities of artificial intelligence, this innovative device holds great promise in improving patient outcomes and reducing the incidence of life-threatening events related to blood clot formation.
We are committed to promoting health, extending life expectancy, and enhancing overall quality of life. Through our innovative contributions, we aim to make a significant impact in improving healthcare outcomes for individuals worldwide.

Based in
Courroux
Tags
thrombosis risk, diagnosis, prevention
Total Funding
Between €1-€100K
Founded
2022
Website
www.aimorphous.health
Company Status
Active
💡 You're a corporate or investor and looking for startups that are innovating in the same market as Aimorphous Health? We're happy to assist you with our Startup Sourcing service.